VACC
Income statement / Annual
Last year (2022), Vaccitech plc's total revenue was $44.70 M,
an increase of 16,580.22% from the previous year.
In 2022, Vaccitech plc's net income was $5.34 M.
See Vaccitech plc�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$44.70 M
|
$268,000.00
|
$4.82 M
|
$6.85 M
|
| Cost of Revenue |
$42.35 M |
$20.37 M |
$14.39 M |
$29.84 M |
| Gross Profit |
$2.35 M |
-$20.10 M |
-$9.57 M |
-$23.00 M |
| Gross Profit Ratio |
0.05 |
-75.01 |
-1.98 |
-3.36 |
| Research and Development
Expenses |
$41.11 M
|
$16.37 M
|
$11.11 M
|
$29.84 M
|
| General & Administrative
Expenses |
$6.39 M
|
$25.12 M
|
$10.48 M
|
$2.67 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$6.39 M
|
$25.12 M
|
$10.48 M
|
$2.67 M
|
| Other Expenses |
$567,000.00 |
$332,000.00 |
$41,690.00 |
$0.00 |
| Operating Expenses |
$47.50 M |
$41.49 M |
$21.59 M |
$391,957.00 |
| Cost And Expenses |
$47.50 M |
$41.49 M |
$21.59 M |
$30.23 M |
| Interest Income |
$3.10 M |
$2,000.00 |
$265.00 |
$92,551.00 |
| Interest Expense |
$19,000.00 |
$2.67 M |
$3.60 M |
$0.00 |
| Depreciation &
Amortization |
$4.32 M
|
$4.34 M
|
$3.53 M
|
$345,431.00
|
| EBITDA |
$869,000.00
|
-$45.22 M
|
-$16.52 M
|
-$22.52 M
|
| EBITDA Ratio |
0.02 |
-152.56 |
-3.43 |
-3.29 |
| Operating Income Ratio
|
-0.08
|
-168.74
|
-4.16
|
-3.31
|
| Total Other
Income/Expenses Net |
$4.89 M
|
-$5.92 M
|
$2.21 M
|
-$9,099.00
|
| Income Before Tax |
$850,000.00 |
-$51.14 M |
-$17.84 M |
-$22.70 M |
| Income Before Tax Ratio
|
0.02
|
-190.82
|
-3.7
|
-3.32
|
| Income Tax Expense |
-$4.47 M |
-$28,000.00 |
$95,010.00 |
-$1.97 M |
| Net Income |
$5.34 M |
-$51.11 M |
-$17.93 M |
-$20.73 M |
| Net Income Ratio |
0.12 |
-190.72 |
-3.72 |
-3.03 |
| EPS |
0.14 |
-1.97 |
-2.27 |
-883.28 |
| EPS Diluted |
0.14 |
-1.97 |
-2.27 |
-883.28 |
| Weighted Average Shares
Out |
$37.25 M
|
$25.89 M
|
$7.90 M
|
$23,469.00
|
| Weighted Average Shares
Out Diluted |
$38.17 M
|
$25.89 M
|
$7.90 M
|
$23,469.00
|
| Link |
|
|
|
|
